Patents or patients? global access to pharmaceuticals and social justice

By de Wildt Gilles   Khoon Chan Chee  

Medicine, Conflict and Survival, Vol. 24, Iss. 1, 2008-01 ,pp. : 52-61

Routledge Ltd

Access to resources Recommend Favorite

Trading risks for markets: the international harmonisation of pharmaceuticals regulation

By Abraham John   Reed Tim  

Health, Risk & Society, Vol. 3, Iss. 1, 2001-03 ,pp. : 113-128

Routledge Ltd

Access to resources Recommend Favorite

Comparison of participants and non-participants in patient-reported outcome surveys: the case of Assessment of Patterns of Patient-Reported Outcomes in Adults with Congenital Heart disease – International Study

By  

Cardiology in the Young, Vol. 27, Iss. 3, 2016-05 ,pp. : 427-434

Cambridge University Press

Access to resources Recommend Favorite

Orphan drugs: pricing, reimbursement and patient access

By Barak Adam   Nandi Jyoti Shankar  

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 5, Iss. 4, 2011-11 ,pp. : 299-317

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Use of the International Classification of Functioning, Disability and Health to Describe Patient-Reported Disability: A Comparison of Guillain-Barré Syndrome with Multiple Sclerosis in a Community Cohort

By Khan Fary   Amatya Bhasker   Ng Louisa  

Journal of Rehabilitation Medicine, Vol. 42, Iss. 8, 2010-09 ,pp. : 708-714

Medical Journals Limited

Access to resources Recommend Favorite